These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24304030)

  • 1. Production of heparan sulfate in the process of calcium oxalate microlith formation.
    Nishio S; Sato T; Yokoyama M; Iwata H; Takeuchi M
    Int J Urol; 1996 Jan; 3(1 Suppl):S69-71. PubMed ID: 24304030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on urolithiasis. The histochemistry of the kidney tissues and stones from patients with urolithiasis].
    Tsai S
    Hinyokika Kiyo; 1986 Jan; 32(1):27-42. PubMed ID: 2938457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies of adhesion and endocytosis of calcium oxalate crystals in renal tubular cells.
    Kohjimoto Y; Ebisuno S; Tamura M; Ohkawa T
    Int J Urol; 1996 Jan; 3(1 Suppl):S72-5. PubMed ID: 24304031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis.
    Chen YH; Liu HP; Chen HY; Tsai FJ; Chang CH; Lee YJ; Lin WY; Chen WC
    Kidney Int; 2011 Aug; 80(4):369-77. PubMed ID: 21451462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate (HS)/heparan sulfate proteoglycan (HSPG) and bikunin are up-regulated during calcium oxalate nephrolithiasis in rat kidney.
    Eguchi Y; Inoue M; Iida S; Matsuoka K; Noda S
    Kurume Med J; 2002; 49(3):99-107. PubMed ID: 12471724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention of calcium oxalate crystals in renal tubules.
    Khan SR; Hackett RL
    Scanning Microsc; 1991 Sep; 5(3):707-11; discussion 711-2. PubMed ID: 1808708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of glycosaminoglycans on calcium oxalate crystal formation].
    Shirane Y; Hamao T; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1065-70. PubMed ID: 2214470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion and endocytosis of calcium oxalate crystals on renal tubular cells.
    Kohjimoto Y; Ebisuno S; Tamura M; Ohkawa T
    Scanning Microsc; 1996; 10(2):459-68; discussion 468-70. PubMed ID: 9813624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of glycosaminoglycans in tubular epithelial cells: calcium oxalate and oxalate ions effects.
    Borges FT; Michelacci YM; Aguiar JA; Dalboni MA; Garófalo AS; Schor N
    Kidney Int; 2005 Oct; 68(4):1630-42. PubMed ID: 16164640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent study on the interaction between collagen and calcium oxalate crystals in the renal tubules.
    Kohri K; Kodama M; Ishikawa Y; Katayama Y; Matsuda H; Imanishi M; Takada M; Katoh Y; Kataoka K; Akiyama T
    Eur Urol; 1991; 19(3):249-52. PubMed ID: 1855532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.
    Yamaguchi S; Yoshioka T; Utsunomiya M; Koide T; Osafune M; Okuyama A; Sonoda T
    Urol Res; 1993 May; 21(3):187-92. PubMed ID: 8342253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis.
    Iida S; Inoue M; Yoshii S; Yanagaki T; Chikama S; Shimada A; Matsuoka K; Noda S; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S412-6. PubMed ID: 10541275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microgenesis of some renal calculi.
    Lilien OM; Hammond WS; Krauss DJ; Elbadawi A; Schoonmaker JE
    Invest Urol; 1981 May; 18(8):451-6. PubMed ID: 7014516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrarenal calcium crystallization. An electron microscopy study].
    Hering F; Burschardt WG
    Urologe A; 1986 Mar; 25(2):116-9. PubMed ID: 3716039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanism of renal stone formation].
    Hamamoto S; Taguchi K; Fujii Y
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature.
    Khan SR; Hackett RL
    Scan Electron Microsc; 1985; (Pt 2):759-74. PubMed ID: 3901237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight dextran sulfate prevents experimental urolithiasis in rats.
    Tostes V; Martinusso CA; Werneck CC; Mourão PA; Cardoso LR
    Clin Chim Acta; 2004 Mar; 341(1-2):147-55. PubMed ID: 14967171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Aerva lanata on calcium oxalate urolithiasis in rats.
    Soundararajan P; Mahesh R; Ramesh T; Begum VH
    Indian J Exp Biol; 2006 Dec; 44(12):981-6. PubMed ID: 17176671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.